Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-04-28

Clinical Trial Update: Topical Aluminium Chloride vs OnabotulinumtoxinA Intradermal Injections in Residual Limb Hyperhidrosis (Lower Limbs) [Phase 3]

View source ↗

Summary

Phase 3 trial comparing topical aluminium chloride to onabotulinumtoxinA intradermal injections for residual limb hyperhidrosis in the lower limbs; completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • aluminium chloride topical (aluminium chloride)
  • onabotulinumtoxinA intradermal injections (onabotulinumtoxinA)

Snippet

Sponsor: Direction Centrale du Service de Santé des Armées | Conditions: Hyperhidrosis, Residual Limbs | Phase 3 | Status: COMPLETED